1-Nitro-9-[(2-aminoethyl)amino]acridines
Inorganic Chemistry, Vol. 35, No. 4, 1996 877
Table 1. Crystallographic Data for 1‚CHCl3 and 3‚1/2CH2Cl2
configuration. In contrast, the nitro substituent in the positions
2 and 3 ensures planarity of the acridine moiety and amino-
type configuration. In the imino tautomer the C(9)-N bond
order increases with respect to that of the amino tautomer, and
accordingly, the bond length becomes shorter.
Also in water solution, at physiological pH (7-8), 1-ni-
troacridines have the usual imino-type configuration while 2-
and 3-nitroacridines are again present in the amino form.10 The
lower pKa values observed for 1-nitroacridines as compared to
those of 2-, 3-, and 4-nitro isomers go along with their preference
for the imino tautomeric form.7
The presence of the imino tautomer appears to be relevant
to the biological activity of these molecules. Hypoxia selective
cytotoxicity is exhibited by 1- and 4-nitroacridines. In the latter
case, in which an equilibrium between imino and amino
tautomers is present, the cytotoxic activity appears to correlate
with the percentage of imino tautomer.11
1‚CHCl3
3‚1/2CH2Cl2
formula
a, Å
b, Å
C18H18Cl4N4O2Pt
8.715(1)
11.045(2)
22.609(4)
90
90
90
2176(1)
1.919
4
C35.5H33Cl2N4O2PPt
13.418(3)
14.053(3)
18.918(4)
90
97.21(3)
90
3539(2)
1.585
4
c, Å
R, deg
â, deg
γ, deg
V, Å3
F
Z
calcd, g‚cm-3
fw
628.6
P212121 (no. 19)
25
844.6
P21/c (no. 14)
25
space group
T, °C
λ, Å
0.71073
70.2
0.48, 0.93
0.0559
0.0561
0.71073
42.37
0.54, 0.96
0.0591
µ (Mo KR), cm-1
transm coeff
R(Fo)a
Rw(Fo)b
0.0611
A greater anticancer activity has been found when the side
chain in the 9-position bears a second amine functionality and
two or three methylene spacers are placed in between the two
nitrogens.6 The diamine chain, with the two nitrogen atoms
separated by two or three carbon spacers, is proposed to play a
crucial role in the metabolic activation of such a drug.
These acridines are also amenable to coordination studies
toward platinum. The diamine chain could act as a bidentate
ligand toward platinum; in this way a powerful alkylating agent
would be incorporated in the acridine molecule and a prelimi-
nary metabolic activation for its biological action could no
longer be required.12 Coordination to a metal atom is also likely
to induce variations in the amino-imino tautomerism.
In this paper we report on the synthesis and structural
characterization of some platinum(II) complexes with 1-nitro-
9-[(2-(dialkylamino)ethyl)amino]acridines.
b
a R(Fï) ) ∑|Fo - |Fc||/∑Fo. Rw(Fï) ) w|Fo - |Fc||/∑ w.
x
x
to prevent contact with moist air. During the reaction time, the [PtCl2-
(DMSO)2] progressively dissolved and a deep red color developed. An
excess of LiCl (2-3 mmol) was then added, and the mixture was kept
stirring for an additional 2 h (the need for this step is commented on
later in this section). The reaction solution was concentrated and then
chromatographed over a silica gel column. The first yellow fraction,
eluted with CH2Cl2, contained a few milligrams of the product of
hydrolysis of A1 to the corresponding 9-acridone. The main fraction
was eluted with dichloromethane containing 3% (v/v) acetone. Evapo-
ration to dryness under reduced pressure gave a dark red crystalline
solid [PtCl(A1-H)] which always contained some solvent of crystal-
lization. Small amounts of other products could be eluted using higher
contents of acetone (>10%, v/v), but they have not been identified at
this stage of the work. The yield of desired product was 60% relative
to platinum. Anal. Calcd for C17H17ClN4O2Pt‚1/2CH2Cl2: C, 36.1; H,
3.1; N, 9.6; Cl, 12.2. Found: C, 36.0; H, 3.2; N, 9.4; Cl, 12.0.
[PtCl(A2-H)], 2. Compound 2 was prepared in a similar way as 1.
In this case, however, the acridine, A2, was available as a dihydro-
chloride salt and the free base was formed in situ by addition of the
stoichiometric amount of LiOH. In spite of the water formed in the
neutralization reaction, the content of 9-acridone was almost as low as
that in the previous case (probably the formed LiCl did act as a drying
agent). Yield: 55%. Anal. Calcd for C19H21ClN4O2Pt‚1/2CH2Cl2: C,
38.4; H, 3.6 N, 9.2; Cl, 11.6. Found: C, 39.2; H, 3.9; N, 8.9; Cl,
11.2.
Experimental Section
Starting Materials. The complex [PtCl2(DMSO)2] was prepared
according to ref 13. Dry chlorinated solvents were obtained by
distillation from calcium hydride. 1-Nitro-9-[(2-(dimethylamino)ethyl)-
amino]acridine, A1, and 1-nitro-9-[(2-(diethylamino)ethyl)amino]acri-
dine, A2, were prepared according to ref 8b.
Preparation of Complexes. [PtCl(A1-H)], 1. Compound 1 was
prepared by reaction of [PtCl2(DMSO)2] with ligand A1 in dry CH2Cl2
(in a typical experiment 1 mmol of both reagents and 10 mL of solvent
were used). The mixture was refluxed for 4 h in an argon atmosphere
[Pt(A1-H)(PPh3)]Cl, 3. A 25 mg (0.04 mmol) sample of 1 was
dissolved in 3 mL of dichloromethane and treated with a 3-fold excess
of triphenylphosphine. The solution was kept stirring for 2 h at room
temperature. Meanwhile, a color change from violet-red to orange-
red took place. The solvent was evaporated under reduced pressure,
and the solid residue was repeatedly washed with pentane to remove
unreacted phosphine and then dried in Vacuo. It proved to be the
product of incorporation of one molecule of triphenylphosphine in 1;
the yield was quantitative. Anal. Calcd for C35H32ClN4O2Pt: C, 52.4;
H, 4.0; N, 7.0; Cl, 4.4. Found: C, 52.6; H, 4.1; N, 6.8; Cl, 4.1.
Physical Measurements. Infrared spectra were recorded as KBr
(in the range 4000-400 cm-1) or polythene pellets (in the range 400-
200 cm-1) on a Perkin-Elmer 283 spectrophotometer. Proton NMR
spectra were recorded on Varian XL 200 and Bruker AM 300 and AM
500 spectrometers.
X-ray Crystallography for 1. Crystals of 1 were grown from
CHCl3 solution. A well-formed red prism was selected for the X-ray
analysis. Crystallographic data are listed in Table 1. Unit cell
parameters were obtained by least-squares refinement of the values (in
the range 2θ ) 10-25°) of 28 carefully centered reflections chosen
from different regions of the reciprocal space. On the basis of the
systematic extinctions, the space group was selected as P212121. This
choice was in agreement with the analysis of the normalized structure
factors which indicated a non-centrosymmetric space group (|E2 - 1|
) 0.659, 0.736 for non-centrosymmetric space groups, and 0.968 for
(9) Dauter, Z.; Bogucka-Ledokowska, M.; Hempel, A.; Ledochowski, A.;
Kosturkiewic, Z. Rocz. Chem. 1975, 49, 859. Hempel, A.; Hull, S.
E.; Bogucka-Ledokowska, M.; Dauter, Z. Acta Crystallogr., Sect. B
1979, B35, 474. Hempel, A.; Hull, S. E.; Dauter, Z.; Bogucka-
Ledokowska, M.; Konitz, A. Acta Crystallogr., Sect. B 1979, B35,
477. Skonieczny, S.; Ledochowski, A. Heterocycles 1979, 4, 1693.
Stallings, W. C.; Glusker, J. P.; Carrell, H. L.; Stezowski, J. J.;
Bogucka-Ledokowska, M.; Ledochowski, A. J. Biomol. Struct. Dynam.
1984, 2, 511. Pett, V. B.; Rossi, M.; Glusker, J. P.; Stezowski, J. J.;
Bogucka-Ledokowska, M. Bioorg. Chem. 1982, 11, 443. Stezowski,
J. J.; Kollat, P.; Bogucka-Ledokowska, M.; Glusker, J. P. J. Am. Chem.
Soc. 1985, 107, 2067.
(10) The position of the tautomeric equilibrium is also influenced by the
solvent. In solvents of low polarity all nitroacridines have the aminic
conformation with the only exception of the 4-nitro isomer for which
an equilibrium between both tautomeric forms is found.7 Calculations
performed on different nitroisomers have assigned lower dipole
moment to the amino tautomer for all nitro isomers with the only
exception of the 4-nitro species. See: Tempczyk, A.; Rak, J.;
Blazejowski, J. J. Chem. Soc., Dalton Trans. 1990, 1501.
(11) Denny, A. J. Med. Chem. 1990, 33, 1288.
(12) Bowler, B. E.; Hollis, L. S.; Lippard, S. J. J. Am. Chem. Soc. 1984,
106, 6102. Bowler, B. E.; Lippard, S. J. Biochemistry 1986, 25, 3031.
Bowler, B. E.; Amhed, K. J.; Sundquist, W. I.; Hollis, L. S.; Whang,
E. E.; Lippard, S. J. J. Am. Chem. Soc. 1989, 111, 1299.
(13) Kukushkin, Yu. N.; Vyaz’menskii, Yu. E.; Zorina, L. I.; Pazukhina,
Yu. L. Russ. J. Inorg. Chem. (Engl. Transl.) 1968, 13, 835.